IPO registrations (S-1, F-1) · Registrants
SomaLogic, Inc.
- SEC CIK
- 1837412 · filings on EDGAR ↗
- Former names
- CM Life Sciences II Inc. (2020–2021)
- Registration
- Form S-1, first filed 2021-02-01, last 2021-10-08; 2 initial registrations, 2 amendments
- Outcome
- Final prospectus filed 2021-02-24; declared effective 2021-02-22
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- C/O SOMALOGIC, INC., 2945 WILDERNESS PLACE, Boulder, CO 80301
- EIN
- 85-4298912
- EDGAR entity type
- operating
- Insiders and CEO pay
- SomaLogic, Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2021-02-24, an initial public offering)
- Shares sold
- 20,000,000
- Listing
- Nasdaq under the symbol CMII
- Lead underwriters
- Jefferies (24,000,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: SOMALOGIC, INC. Fuzzy (name and state)
- Lobbying client: SOMALOGIC Fuzzy (name and state)
- SEC filer: CM Life Sciences II Inc. EXACT (CIK (EXACT))
- Person page: Anne H Margulies Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner))
- Person page: Charles M Lillis Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Thomas D Carey Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 12
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-02-01 | S-1 | S-1 (registration) | CM Life Sciences II Inc. | 0001213900-21-005846 ↗ |
| 2021-02-12 | S-1/A | S-1/A (amendment) | CM Life Sciences II Inc. | 0001213900-21-009081 ↗ |
| 2021-02-22 | S-1MEF | S-1MEF (added securities) | CM Life Sciences II Inc. | 0001213900-21-010969 ↗ |
| 2021-02-22 | EFFECT | EFFECT (declared effective) | CM Life Sciences II Inc. | 9999999995-21-000702 ↗ |
| 2021-02-24 | 424B4 | 424B4 (final prospectus) | CM Life Sciences II Inc. | 0001213900-21-011418 ↗ |
| 2021-08-12 | EFFECT | EFFECT (declared effective) | CM Life Sciences II Inc. | 9999999995-21-003175 ↗ |
| 2021-10-01 | S-1 | S-1 (registration) | SomaLogic, Inc. | 0001213900-21-051049 ↗ |
| 2021-10-08 | S-1/A | S-1/A (amendment) | SomaLogic, Inc. | 0001213900-21-052074 ↗ |
| 2021-10-14 | EFFECT | EFFECT (declared effective) | SomaLogic, Inc. | 9999999995-21-003885 ↗ |
| 2022-10-18 | EFFECT | EFFECT (declared effective) | SomaLogic, Inc. | 9999999995-22-003064 ↗ |
| 2022-11-17 | EFFECT | EFFECT (declared effective) | SomaLogic, Inc. | 9999999995-22-003330 ↗ |
| 2023-05-01 | EFFECT | EFFECT (declared effective) | SomaLogic, Inc. | 9999999995-23-001220 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-02-12 | S-1/A | registration statement | $10.00 | 20,000,000 | $200,000,000 | Nasdaq CMII | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ | |
| 2021-02-24 | 424B4 | final prospectus | $10.00 | - | - | Nasdaq CMII | 1 | primary document; price sentence, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Casdin Eli | Director; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Executive Officer | 7 | 2021–2024 | |
| C-LSH II LLC | TenPercentOwner | 1 | 2021 | ||
| CMLS Holdings II LLC | TenPercentOwner | 1 | 2021 | ||
| Conroy Kevin T | Director | 2 | 2021 | ||
| Cox Troy | Director; Director,Officer | Executive Chair | 7 | 2021–2024 | |
| Emes Brian | Officer | CFO and Secretary | 1 | 2021 | |
| Kelly Jason R | Director | 1 | 2021 | ||
| Meister Keith A. | Director,TenPercentOwner | 1 | 2021 | ||
| M-LSH II LLC | TenPercentOwner | 1 | 2021 | ||
| Quake Stephen | Director | 4 | 2021–2022 | ||
| Rodriguez Shaun | Officer | Chief Strategy Officer | 1 | 2021 | |
| BARCHI ROBERT | Director | 6 | 2021–2024 | ||
| Blakeman Shaun M. | Officer | Chief Financial Officer | 4 | 2021–2023 | |
| Graves Amy | Officer | Chief Accounting Officer; SVPF | 5 | 2021–2023 | |
| Gutierrez Ruben | Officer | General Counsel | 8 | 2021–2024 | |
| Harris Melody | Officer | President and COO | 3 | 2021–2022 | |
| Lillis Charles M. | Director | 4 | 2021–2023 | person page Fuzzy | |
| Margulies Anne H. | Director; Director,TenPercentOwner | 7 | 2021–2024 | person page Fuzzy | |
| MEISEL TED D | Director | 4 | 2021–2023 | ||
| POST RICHARD A | Director | 8 | 2021–2024 | ||
| Smythe Roy | Director,Officer | Chief Executive Officer | 4 | 2021–2022 | |
| Carey Thomas D. | Director | 3 | 2023–2024 | person page Fuzzy | |
| HIBBS KATHY L | Director | 3 | 2023–2024 | ||
| Ryan Jason | Director | 3 | 2023–2024 | ||
| Taich Adam | Officer | Interim CEO | 4 | 2023–2024 | |
| PETERSON TYCHO | Director | 3 | 2023–2024 | ||
| Lurier Eliot M | Officer | Interim CFO | 1 | 2023 | |
| Roelke Alison Marie | Officer | Chief People Officer | 5 | 2023–2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | SOMALOGIC, INC. | CO | State business registries | name and state |
| Contractor | SOMALOGIC | CO | Nonprofit contractors (Form 990) | name and state |
| Plan sponsor | SOMALOGIC, INC. | CO | Form 5500 (employee benefit plans) | name and state |
| Form D issuer | SOMALOGIC, INC | CO | Form D private offerings | name and state |
| Lobbying client | SOMALOGIC | CO | Federal lobbying (LDA) | name and state |
| Patent assignee | SomaLogic, Inc. | CO | Patents (USPTO) | name and state |
| SEC filer | SomaLogic, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | SomaLogic, Inc. | CO | Trademarks (USPTO) | name and state |
| Person page | Anne H Margulies | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner) | |
| Person page | Charles M Lillis | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Thomas D Carey | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, CO first:
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- DGI RESOLUTION INC K6
- PRA INTERNATIONAL INC VA
- QUEST DIAGNOSTICS INVESTMENTS INC NJ
- SIGNAL PHARMACEUTICALS INC CA
- CURAGEN CORP MA
- DELTAGEN INC CA
- BIORELIANCE CORP MD
- KENDLE INTERNATIONAL INC OH
In other datasets, the same topic (Medical research) in CO:
- Form D issuer: ACESIS HOLDINGS CORP. (Form D private offerings)
- Nonprofit: 2 GENERATIONS CRISIS (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research